ArticlePublic health challenges2024
COVID-19 herd immunity in Lebanon: Challenges and prospects.
Article in Public health challenges, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- COVID-19 herd immunity in Lebanon: Challenges and prospects.Public health challenges · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 hit Lebanon at the worst time, amid an economic downward spiral and national protests regarding living conditions and political corruption. The first case was found on February 21, 2020, and the first batch of vaccines arrived on March 24, 2021. Although neither natural infection nor mass vaccination truly provided herd immunity, the latter was a more effective way to handle the pandemic, and Lebanon fell short on that path. During the pandemic, a myriad of factors complicated its response to the virus. Thanks to the COVAX program, the country received 1086,720 doses donated and 1626,390 deliveries. All in all, over 5.8 million doses have been administered. A total of 2.74 million people received at least one dose, and 2.4 million had a complete primary vaccination series. However, around 98% of the population were infected with the virus. Issues that stopped the vaccination campaigns include a lack of trust in government officials and news media, leading to false information propagating and remaining unchallenged online. Other factors include the economic collapse, which led to the Lebanese currency losing over 98% of its initial worth. Some Lebanese people might find themselves either unable to reach proper health facilities or unwilling to adopt the narrative pushed by the political elite. Poverty also worsened affected infected individuals' prognosis and mortality. A bigger emphasis must be put on reaching individuals with disabilities or in low-income areas, as they were the most affected by the pandemic. Problems these communities face include the lack of funding for special education schools and the lack of accessibility to medical information promoted by the government. Lebanon must learn from the issues that arose during this pandemic and focus on fixing them in advance to prepare for any other health emergency that might turn up in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.